Filing Details

Accession Number:
0001209191-17-058477
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-10-31 18:12:05
Reporting Period:
2017-10-31
Accepted Time:
2017-10-31 18:12:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1406338 Amit Sachdev C/O Vertex Pharmaceuticals Incorporated
50 Northern Avenue
Boston MA 02210
Evp, Cro No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-10-31 900 $142.40 89,810 No 4 S Direct
Common Stock Disposition 2017-10-31 2,800 $143.49 87,010 No 4 S Direct
Common Stock Disposition 2017-10-31 17,362 $144.47 69,648 No 4 S Direct
Common Stock Disposition 2017-10-31 12,438 $145.26 57,210 No 4 S Direct
Common Stock Disposition 2017-10-31 3,200 $146.53 54,010 No 4 S Direct
Common Stock Disposition 2017-10-31 2,200 $147.70 51,810 No 4 S Direct
Common Stock Disposition 2017-10-31 1,000 $148.35 50,810 No 4 S Direct
Common Stock Disposition 2017-10-31 100 $149.34 50,710 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 882 Indirect 401(k)
Footnotes
  1. Transaction made pursuant to Mr. Sachdev's company-approved trading plan under Rule 10b5-1.
  2. Open market sales reported on this line occurred at a weighted average price of $142.40 (range $141.83 to $142.70).
  3. Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
  4. Open market sales reported on this line occurred at a weighted average price of $143.49 (range $142.87 to $143.85).
  5. Open market sales reported on this line occurred at a weighted average price of $144.47 (range $143.90 to $144.89).
  6. Open market sales reported on this line occurred at a weighted average price of $145.26 (range $144.93 to $145.87).
  7. Open market sales reported on this line occurred at a weighted average price of $146.53 (range $146.16 to $147.14).
  8. Open market sales reported on this line occurred at a weighted average price of $147.70 (range $147.18 to $148.15).
  9. Open market sales reported on this line occurred at a weighted average price of $148.35 (range $148.19 to $148.70).